• 1
    Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004;22:789815.
  • 2
    Eapen SS, Busse WW. Asthma. Clin Allergy Immunol 2002;16:325353.
  • 3
    Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002;3:715720.
  • 4
    Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255281.
  • 5
    Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:15271536.
  • 6
    Iwamoto I, Kumano K, Kasai M, Kurasawa K, Nakao A. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am J Respir Crit Care Med 1996;154:12571260.
  • 7
    Herz U, Gerhold K, Gruber C, Braun A, Wahn U, Renz H et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998;102:867874.
  • 8
    Hopfenspirger MT, Agrawal DK. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002;168:25162522.
  • 9
    Hubeau C, Singer M, Lagranderie M, Marchal G, Vargaftig B. Extended freeze-dried Mycobacterium bovis Bacillus Calmette-Guerin induces the release of interleukin-12 but not tumour necrosis factor-alpha by alveolar macrophages, both in vitro and in vivo. Clin Exp Allergy 2003;33:386393.
  • 10
    Lagranderie M, Nahori MA, Balazuc AM, Kiefer-Biasizzo H, Lapa e Silva JR, Milon G et al. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology 2003;108:352364.
  • 11
    Oliveira FH, Sarinho SW, Montenegro S, Neuenschwander C, Queiroz R, Medeiros D et al. Production of interferon gamma in asthmatic patients with small bacille Calmette-Guerin scars: a pilot study. Allergy Asthma Proc 2006;27:516522.
  • 12
    Vargas MH, Bernal-Alcantara DA, Vaca MA, Franco-Marina F, Lascurain R. Effect of BCG vaccination in asthmatic schoolchildren. Pediatr Allergy Immunol 2004;15:415420.
  • 13
    Shen H, Huang H, Wang J, Ye S, Li W, Wang K et al. Neonatal vaccination with Bacillus Calmette-Guerin elicits long-term protection in mouse-allergic responses. Allergy 2008;63:555563.
  • 14
    Christ AP, Rodriguez D, Bortolatto J, Borducchi E, Keller A, Mucida D et al. Enhancement of Th1 lung immunity induced by recombinant Mycobacterium bovis Bacillus Calmette-Guerin attenuates airway allergic disease. Am J Respir Cell Mol Biol 2010;43:243252.
  • 15
    Jung YJ, Ryan L, LaCourse R, North RJ. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2005;201:19151924.
  • 16
    Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4 +  T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007;8:369377.
  • 17
    Bevan MJ. Immunology: remembrance of things past. Nature 2002;420:748749.
  • 18
    Kipnis A, Irwin S, Izzo AA, Basaraba RJ, Orme IM. Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 Ligandhi population. Infect Immun 2005;73:77597764.
  • 19
    Mora JR, von Andrian UH. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol 2006;27:235243.
  • 20
    Westermann J, Ehlers EM, Exton MS, Kaiser M, Bode U. Migration of naive, effector and memory T cells: implications for the regulation of immune responses. Immunol Rev 2001;184:2037.
  • 21
    Cai Y, Zhou J, Webb DC. Treatment of mice with fenbendazole attenuates allergic airways inflammation and Th2 cytokine production in a model of asthma. Immunol Cell Biol 2009;87:623629.
  • 22
    Idzko M, Hammad H, van Nimwegen M, Kool M, Muller T, Soullie T et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 2006;116:29352944.
  • 23
    Martin-Fontecha A, Baumjohann D, Guarda G, Reboldi A, Hons M, Lanzavecchia A et al. CD40L+ CD4 +  memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming. J Exp Med 2008;205:25612574.
  • 24
    Pakpour N, Zaph C, Scott P. The central memory CD4 +  T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma. J Immunol 2008;180:82998305.
  • 25
    Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, Donnarumma M et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008;205:31333144.
  • 26
    Henao-Tamayo MI, Ordway DJ, Irwin SM, Shang S, Shanley C, Orme IM. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol 2010;17:618625.
  • 27
    Connor LM, Harvie MC, Rich FJ, Quinn KM, Brinkmann V, Le Gros G et al. A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination. Eur J Immunol 2010;40:24822492.
  • 28
    Badovinac VP, Porter BB, Harty JT. Programmed contraction of CD8(+) T cells after infection. Nat Immunol 2002;3:619626.
  • 29
    Mathurin KS, Martens GW, Kornfeld H, Welsh RM. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol 2009;83:35283539.
  • 30
    Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167:14811497.
  • 31
    Fonseca DM, Paula MO, Wowk PF, Campos LW, Gembre AF, Turato WM et al. IFN-gamma-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN. Immunol Cell Biol 2011;89:777785.
  • 32
    Campbell JD, Gangur V, Simons FE, HayGlass KT. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J 2004;18:329331.